Geostatistical analysis of baseline prevalence and treatment history drastically reduces the cost of soil-transmitted helminth impact assessment surveys.
7 affiliations
- 1Department of Applied Health Sciences, University of Birmingham, Birmingham, UK. [email protected].
- 2Centre for Health Informatics, Computing and Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster, UK. [email protected].
- 3Department of Mathematics, University of Manchester, Manchester, UK.
- 4Department of Applied Health Sciences, University of Birmingham, Birmingham, UK.
- 5Centre for Health Informatics, Computing and Statistics (CHICAS), Lancaster Medical School, Lancaster University, Lancaster, UK.
- 6Department of Control of Neglected Tropical Diseases, WHO, Geneva, Switzerland.
- 7Ivo de Carneri Foundation, Milan, Italy.
Abstract
Background
Impact assessment surveys (IAS) are central to monitoring and evaluating the effectiveness of mass drug administration (MDA) programs targeting soil-transmitted helminths (STH). Current survey designs often follow guidelines that lack flexibility and spatial representativeness. There is a need for more efficient and context-adaptable methodologies that can guide programmatic decision-making using available data.Methods
We developed a three-step geostatistical framework for optimal IAS design that integrates baseline prevalence data, environmental covariates, and treatment history. A geostatistical model is used to estimate baseline prevalence. A Markov model, coupled with a local spatial thinning algorithm, is then applied to forecast post-MDA prevalence surfaces. These projections guide the simulation and evaluation of candidate survey designs across different sampling intensities and spatial configurations. Design performance was assessed based on classification accuracy and survey cost.Results
The methodology was applied to datasets from Kenya, Sierra Leone, and Zimbabwe. Compared to conventional survey designs, our model-based approach achieved similar classification accuracy with 60-90% lower survey costs. These gains were consistent across settings with different endemicity levels and deworming histories. The results also highlight the importance of leveraging spatial correlation and historical program data to inform efficient design.Conclusions
Our approach offers a flexible and cost-effective solution for designing IAS under real-world constraints. By incorporating spatial modeling and intervention history, it enables evidence-based decision-making and resource allocation. This framework is disease-agnostic and can be adapted to other neglected tropical diseases to support progress toward control and elimination goals.
Related
- Drinking water treatment drastically modifies multi-kingdom water communities, but clinically relevant opportunistic bacterial pathogens persist
- An updated review of monkeypox virus infection's global prevalence and health risks with supporting treatment and diagnosis
- Prevalence and Treatment of Macrolide-Resistant Mycoplasma pneumoniae Infections in Singapore
- Hemodynamic-Structural Multi-Fidelity Assessment of Endovascular Flow Diversion Strategies for Cerebral Aneurysm Treatment: An Integrated Computational and Experimental Framework
- Prevalence and predictors of risk factors for non-communicable diseases in individuals aged 10–30 years: Findings from baseline cross-sectional assessment of V-CaN
BibTeX
@article{fronterre2026geostatistical,
title = {{Geostatistical analysis of baseline prevalence and treatment history drastically reduces the cost of soil-transmitted helminth impact assessment surveys.}},
author = {Claudio Fronterre and Olatunji Johnson and Emanuele Giorgi and Antonio Montresor and Peter J Diggle},
journal = {BMC global and public health},
year = {2026},
month = oct,
doi = {10.1186/s44263-026-00304-8},
url = {https://europepmc.org/article/MED/42919436},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Geostatistical analysis of baseline prevalence and treatment history drastically reduces the cost of soil-transmitted helminth impact assessment surveys.
AU - Claudio Fronterre
AU - Olatunji Johnson
AU - Emanuele Giorgi
AU - Antonio Montresor
AU - Peter J Diggle
PY - 2026
DA - 2026/10/22
JO - BMC global and public health
DO - 10.1186/s44263-026-00304-8
UR - https://europepmc.org/article/MED/42919436
AB - Background Impact assessment surveys (IAS) are central to monitoring and evaluating the effectiveness of mass drug administration (MDA) programs targeting soil-transmitted helminths (STH). Current survey designs often follow guidelines that lack flexibility and spatial representativeness. There is a need for more efficient and context-adaptable methodologies that can guide programmatic decision-making using available data.Methods We developed a three-step geostatistical framework for optimal IAS design that integrates baseline prevalence data, environmental covariates, and treatment history. A geostatistical model is used to estimate baseline prevalence. A Markov model, coupled with a local spatial thinning algorithm, is then applied to forecast post-MDA prevalence surfaces. These projections guide the simulation and evaluation of candidate survey designs across different sampling intensities and spatial configurations. Design performance was assessed based on classification accuracy and survey cost.Results The methodology was applied to datasets from Kenya, Sierra Leone, and Zimbabwe. Compared to conventional survey designs, our model-based approach achieved similar classification accuracy with 60-90% lower survey costs. These gains were consistent across settings with different endemicity levels and deworming histories. The results also highlight the importance of leveraging spatial correlation and historical program data to inform efficient design.Conclusions Our approach offers a flexible and cost-effective solution for designing IAS under real-world constraints. By incorporating spatial modeling and intervention history, it enables evidence-based decision-making and resource allocation. This framework is disease-agnostic and can be adapted to other neglected tropical diseases to support progress toward control and elimination goals.
SN - 2731-913X
ER -